Pheochromocytoma in a patient with end-stage renal disease

被引:0
|
作者
Godfrey, JA
Rickman, OB
Williams, AW
Thompson, GB
Young, WF
机构
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med & Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Nephrol & Internal Med, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Div Hypertens & Internal Med, Rochester, MN 55905 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pheochromocytoma is a rare tumor. To our knowledge only 15 cases have been reported in patients with end-stage renal disease (ESRD). We describe a 46-year-old woman with ESRD and a history of paroxysmal and difficult-to-control hypertension. During anesthesia for a surgical procedure, the patient experienced blood pressure lability with systolic blood pressures ranging from 76 to 360 nun Hg. Serum catecholamine concentrations were 2698 pg/mL (reference value, < 750 pg/mL) for norepinephrine, 33 pg/mL (< 110 pg/mL) for epinephrine, and 55 pg/mL (< 30 pg/mL) for dopamine. The concentrations of plasma metanephrines were 6.84 nmot/L (<0.50 nmol/L) for metanephrine and 14.64 nmol/L (<0.90 nmol/L) for normetanephrine. Abdominal computed tomography showed a right-sided, 4-cm mass posterior to the infrahepatic inferior vena cava. Following blood pressure control with alpha- and beta -adrenergic blockade, the mass was removed. Pathologic examination demonstrated the mass was a pheochromocytoma. The maximum postoperative systolic blood pressure was 160 mm Hg. Postoperative plasma normetanephrine concentration was 2.80 nmol/L, and metanephrine was obscured by interfering substances. This case report and literature review emphasizes the difficulty in diagnosing pheochromocytomas in patients with ESRD despite the myriad of available diagnostic tests.
引用
收藏
页码:953 / 957
页数:5
相关论文
共 50 条
  • [1] Pheochromocytoma in end-stage renal disease patient treated by peritoneal dialysis
    Gorsane, Imen
    Zouaghi, Karim
    Goucha, Rim
    Bacha, Mohamed Mongi
    Hedri, Hafedh
    Khiari, Karima
    Abderrahim, Ezzedine
    Ben Abdallah, Taieb
    Ben Abdallah, Nejib
    Ben Moussa, Fatma
    Ben Maiz, Hedi
    Kheder, Adel
    NEPHROLOGIE & THERAPEUTIQUE, 2008, 4 (07): : 597 - 601
  • [2] Four cases of pheochromocytoma in patients with end-stage renal disease
    Saeki, T
    Suzuki, K
    Yamazaki, H
    Miyamura, S
    Koike, H
    Morishita, H
    Gejyo, F
    INTERNAL MEDICINE, 2003, 42 (10) : 1011 - 1015
  • [3] Calciphylaxis in a patient with end-stage renal disease
    Kim, YJ
    Chung, BS
    Choi, KC
    JOURNAL OF DERMATOLOGY, 2001, 28 (05): : 272 - 275
  • [4] Rash in a Patient With End-Stage Renal Disease
    McConnell, Adam
    Griffin, Sarah Noel
    Miller, Jan
    AMERICAN FAMILY PHYSICIAN, 2024, 110 (01) : 81 - 82
  • [5] Influenza and the patient with end-stage renal disease
    Brendan T. Bowman
    Mitchell H. Rosner
    Journal of Nephrology, 2018, 31 : 225 - 230
  • [6] Influenza and the patient with end-stage renal disease
    Bowman, Brendan T.
    Rosner, Mitchell H.
    JOURNAL OF NEPHROLOGY, 2018, 31 (02) : 225 - 230
  • [7] Hypokalemia in an End-Stage Renal Disease Patient
    Verma, Ashish
    Shahid, Muhammad Hassaan
    Youngblood, Laura
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (09): : E385 - E386
  • [8] Prolonged Unconsciousness in a Patient with End-Stage Renal Disease
    Ghalib, Mohamed B.
    Hassan, Imad Salah
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2006, 17 (02) : 273 - 277
  • [9] Keratotic Nodules in a Patient With End-Stage Renal Disease
    Han, Yuna
    Lee, Michael P.
    Elsensohn, Ashley
    CUTIS, 2023, 112 (05): : 240 - 249
  • [10] Esophageal actinomycosis in a patient with end-stage renal disease
    Nagaraju, Shankar Prasad
    Kirpalani, Dilip Ashok
    Bhabhe, Aditya S.
    Prasad, Raghvendra
    Shah, Hardik
    Kirpalani, Ashok L.
    HEMODIALYSIS INTERNATIONAL, 2014, 18 (02) : 544 - 546